M. D. Anderson Cancer SPORE in Genitourinary Cancers

$2,971,514P50FY2002CANIH

University Of Texas Md Anderson Can Ctr, Houston TX

Investigators

Linked publications & trials

Paper 38676926 Paper 37442564 Paper 37246493 Paper 36404232 Paper 35770498 Paper 34920986 Paper 34184926 Paper 33935020 Paper 33881933 Paper 33783950 Paper 33563539 Paper 33502236 Paper 33258948 Paper 32546765 Paper 32253420 Paper 32122956 Paper 31757304 Paper 31067463 Paper 30415317 Paper 29955780 Paper 29763719 Paper 29660813 Paper 29529165 Paper 29428551 Paper 29235103 Paper 29179475 Paper 29174465 Paper 29088836 Paper 28988769 Paper 28851898 Paper 28834453 Paper 28827100 Paper 28826932 Paper 28823575 Paper 28753816 Paper 28365159 Paper 28149933 Paper 28102366 Paper 28018013 Paper 27845906 Paper 27825764 Paper 27818773 Paper 27797838 Paper 27612592 Paper 27499906 Paper 27494900 Paper 27480598 Paper 27387678 Paper 27291797 Paper 26988609 Paper 26922408 Paper 26907529 Paper 26732427 Paper 26515115 Paper 26464424 Paper 26364859 Paper 26343003 Paper 26280620 Paper 26173102 Paper 26119560 Paper 26032953 Paper 25896234 Paper 25851338 Paper 25443274 Paper 25416716 Paper 25320178 Paper 25219851 Paper 25199718 Paper 25027329 Paper 24931270 Paper 24525232 Paper 24503570 Paper 24449888 Paper 24391818 Paper 24163127 Paper 24121789 Paper 24053608 Paper 23946494 Paper 23911605 Paper 23874968 Paper 23657946 Paper 23553206 Paper 23529717 Paper 23507396 Paper 23500642 Paper 23468956 Paper 23322153 Paper 23284679 Paper 23272234 Paper 23251617 Paper 23239884 Paper 23040072 Paper 22914978 Paper 22895070 Paper 22879988 Paper 22863868 Paper 22742565 Paper 22701660 Paper 22586063 Paper 22583635

Abstract

The overall goal of this University of Texas MD Anderson Cancer Center SPORE is to facilitate innovative translational research in the prevention, detection, and treatment of bladder cancer leading to the elimination of this disease as a major health problem. Our Cancer Center contains a unique concentration of talented investigators who are dedicated to clinical, translational, and fundamental bladder cancer research. Our institution has given high priority to the Bladder Cancer Multi- disciplinary Program. The Program has recruited faculty within the institution, strengthened the research infrastructure, and funded several pilot studies. We are now poised to take advantage of the framework developed by this multi-disciplinary group to enable a rapid increase in the understanding of bladder cancer at the molecular and cellular level. Funding of this SPORE will greatly enhance our ability to translate insights from bladder cancer biology to more effective prevention, detection, and treatment of bladder cancer. The SPORE includes 5 projects that deal with 1) early detection and chemoprevention of bladder cancer, 2) epidemiology of bladder cancer 3) death receptors in bladder cancer progression and therapy, 4) biology and therapeutic targeting of the epidermal growth factor receptor in bladder cancer, and 5) improving gene therapy for superficial bladder cancer. This SPORE addresses clinical dilemmas develop effective strategies for chemoprevention, detection, molecular profiling and therapeutics, bioimmunotherapy, chemotherapy, supportive care, and community awareness.

View original record on NIH RePORTER →